Lista Publikacji

International Hereditary Cancer Centre – selected publications (updated in January 2010)

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy. Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, Wisniowski R, Siolek M, Dent R, Lubinski J, Narod S. J Clin Oncol. 2010

2010

  1. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Tołoczko-Grabarek A, Gilbert M, Edler L, Zapatka M, Eils R, Lubiński J, Scott RJ, Hamann U. Breast Cancer Res Treat. 2010; 119 (1): 201-211.

  2. Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients. Dymerska D, Serrano-Fernández P, Suchy J, Pławski A, Słomski R, Kaklewski K, Scott RJ, Gronwald J, Kładny J, Byrski T, Huzarski T, Lubiński J, Kurzawski G. J Mol Diagn. 2010; 12 (1): 82-90.

2009

  1. The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Wokołorczyk D, Gliniewicz B, Stojewski M, Sikorski A, Złowocka E, Dębniak T, Jakubowska A, Górski B, Wetering TV, Narod SA, Lubiński J, Cybulski C. The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Eur J Cancer Prev. 2009 Nov 27

  2. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma. Morris MR, Hughes DJ, Tian YM, Ricketts CJ, Lau KW, Gentle D, Shuib S, Serrano-Fernandez P, Lubinski J, Wiesener MS, Pugh CW, Latif F, Ratcliffe PJ, Maher ER. Anticancer Res. 2009; 29 (11): 4337-4343.

  3. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer. Bogdanova N, Cybulski C, Bermisheva M, Datsyuk I, Yamini P, Hillemanns P, Antonenkova NN, Khusnutdinova E, Lubinski J, Dörk T. Breast Cancer Res Treat. 2009; 118 (1): 207-211.

  4. Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Dziaman T, Huzarski T, Gackowski D, Rozalski R, Siomek A, Szpila A, Guz J, Lubinski J, Wasowicz W, Roszkowski K, Olinski R. Cancer Epidemiol Biomarkers Prev. 2009; 18 (11): 2923-2928.

  5. Elevated level of 8-oxo-7,8-dihydro-2′-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls. Dziaman T, Huzarski T, Gackowski D, Rozalski R, Siomek A, Szpila A, Guz J, Lubinski J, Olinski R. Int J Cancer. 2009; 125 (9): 2209-2213.

  6. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Lubinski J. Breast Cancer Res Treat. 2009 Oct 30.

  7. CHEK2 mutations and HNPCC – related colorectal cancer. Suchy J, Cybulski C, Wokołorczyk D, Oszurek O, Górski B, Dębniak T, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dziuba I, Gogacz M, Wiśniowski R, Wandzel P, Banaszkiewicz Z, Kurzawski G, Kładny J, Narod SA, Lubiński J. Int J Cancer. 2009 Oct 28.

  8. Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers. Vicus D, Rosen B, Lubinski J, Domchek S, Kauff ND, Lynch HT, Isaacs C, Tung N, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Gynecol Oncol. 2009; 115 (1): 135-137.

  9. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Vasen HF, Möslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Rahner N, Hes FJ, Hodgson S, Mecklin JP, Møller P, Myrhøj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J, Lubinski J, Järvinen H, Claes E, Heinimann K, Karagiannis JA, Lindblom A, Dove-Edwin I, Müller H. Fam Cancer. 2009 Sep 18.

  10. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Serrano-Fernández P, Dębniak T, Górski B, Bogdanova N, Dörk T, Cybulski C, Huzarski T, Byrski T, Gronwald J, Wokołorczyk D, Narod SA, Lubiński J. Breast Cancer Res Treat. 2009; 117 (1): 161-165.

  11. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, Dicioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J, Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, Dürst M, Ekici AB, Fenstermacher D, Fridley BL, Giles G, Gore ME, De Vivo I, Hillemanns P, Hogdall C, Hogdall E, Iversen ES, Jacobs IJ, Jakubowska A, Li D, Lissowska J, Lubiński J, Lurie G, McGuire V, McLaughlin J, Mędrek K, Moorman PG, Moysich K, Narod S, Phelan C, Pye C, Risch H, Runnebaum IB, Severi G, Southey M, Stram DO, Thiel FC, Terry KL, Tsai YY, Tworoger SS, Van Den Berg DJ, Vierkant RA, Wang-Gohrke S, Webb PM, Wilkens LR, Wu AH, Yang H, Brewster W, Ziogas A; Australian Cancer (Ovarian) Study; The Australian Ovarian Cancer Study Group; The Ovarian Cancer Association Consortium, Houlston R, Tomlinson I, Whittemore AS, Rossing MA, Ponder BA, Pearce CL, Ness RB, Menon U, Kjaer SK, Gronwald J, Garcia-Closas M, Fasching PA, Easton DF, Chenevix-Trench G, Berchuck A, Pharoah PD, Gayther SA. Nat Genet. 2009; 41 (9): 996-1000.

  12. Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism. Kładny J, Suchy J, Kłujszo-Grabowska E, Kacperski T, Scott RJ, Kurzawski G, Lubiński J. Cancer Epidemiol. 2009ł 33 (2): 161-163.

  13. Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Gapska P, Scott RJ, Serrano-Fernandez P, Mirecka A, Rassoud I, Górski B, Cybulski C, Huzarski T, Byrski T, Nagay L, Maleszka R, Sulikowski M, Lubinski J, Debniak T. Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Cancer Epidemiol. 2009; 33 (2): 103-107.

  14. Haplotype of the C61G BRCA1 mutation in Polish and Jewish individuals. Kaufman B, Laitman Y, Gronwald J, Lubinski J, Friedman E. Genet Test Mol Biomarkers. 2009; 13 (4): 465-469.

  15. Genome-wide association study identifies three loci associated with melanoma risk. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Chin-A-Woeng T, Debniak T, Galore-Haskel G, Ghiorzo P, Gut I, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Kanetsky PA, Kefford RF, Landi MT, Lang J, Lubiński J, Mackie R, Malvehy J, Mann GJ, Martin NG, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Puig S, Weiss M, van Workum W, Zelenika D, Brown KM, Goldstein AM, Gillanders EM, Boland A, Galan P, Elder DE, Gruis NA, Hayward NK, Lathrop GM, Barrett JH, Bishop JA. Nat Genet. 2009; 41 (8): 920-925.

  16. Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers. Jaworowska E, Tarnowska C, Lubinski J, Serrano-Fernández P, Huzarski T, Górski B, Masojc B, Jakubiszyn J, Korytowska A, Kram A, Rabczynski J, Lubinski J. Anticancer Res. 2009; 29 (7): 2703-2705.

  17. Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age. Shi Z, Johnstone D, Talseth-Palmer BA, Evans TJ, Spigelman AD, Groombridge C, Milward EA, Olynyk JK, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age. Int J Cancer. 2009; 125 (1): 78-83.

  18. Studies on the pharmacokinetics and metabolism of a gamma-secretase inhibitor BMS-299897, and exploratory investigation of CYP enzyme induction. Zheng M, Wang J, Lubinski J, Flint OP, Krishna R, Yao M, Pursley JM, Thakur A, Boulton DW, Santone KS, Barten DM, Anderson JJ, Felsenstein KM, Hansel SB. Xenobiotica. 2009; 39 (7): 544-555.

  19. Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma. Ricketts C, Zeegers MP, Lubinski J, Maher ER. PLoS One. 2009; 4 (6): e6037.

  20. Vitamin D receptor variants and breast cancer risk in the Polish population. Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T, Kładny J, Gronwald J, Górski B, Cybulski C, Lubinski J, Dębniak T. Breast Cancer Res Treat. 2009; 115 (3): 629-633.

  21. Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations. Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K; Public and Professional Policy Committee (PPPC) of the European Society of Human Genetics (ESHG). Eur J Hum Genet. 2009; 17 (6): 711-719.

  22. Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. European Society of Human Genetics. Eur J Hum Genet. 2009; 17 (6): 720-721.

  23. Identification of patients at high risk of psychological distress after BRCA1 genetic testing. Ertmański S, Metcalfe K, Trempała J, Głowacka MD, Lubiński J, Narod SA, Gronwald J. Genet Test Mol Biomarkers. 2009; 13 (3): 325-330.

  24. Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband. Gronwald J, Cybulski C, Piesiak W, Suchy J, Huzarski T, Byrski T, Gorski B, Debniak T, Szwiec M, Wokolowczyk D, Matuszewski M, Sun P, Lubinski J, Narod SA. Br J Cancer. 2009; 100 (9): 1508-1512.

  25. Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Byrski T, Huzarski T, Dent R, Gronwald J, Zuziak D, Cybulski C, Kladny J, Gorski B, Lubinski J, Narod SA. Breast Cancer Res Treat. 2009; 115 (2): 359-363.

  26. MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Reeves SG, Meldrum C, Groombridge C, Spigelman AD, Suchy J, Kurzawski G, Lubinski J, McElduff P, Scott RJ. Eur J Hum Genet. 2009; 17 (5): 629-635.

  27. Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). Willems P, Magri V, Cretnik M, Fasano M, Jakubowska A, Levanat S, Lubinski J, Marras E, Musani V, Thierens H, Vandersickel V, Perletti G, Vral A. Int J Oncol. 2009; 34 (4): 1005-1015.

  28. HLA-G polymorphism and in vitro fertilization failure in a Polish population. Sipak-Szmigiel O, Cybulski C, Wokołorczyk D, Lubiński J, Kurzawa R, Baczkowski T, Radwan M, Radwan P, Ronin-Walknowska E. Tissue Antigens. 2009; 73 (4): 348-352.

  29. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Czarnecka AM, Krawczyk T, Zdrożny M, Lubiński J, Arnold RS, Kukwa W, Scińska A, Golik P, Bartnik E, Petros JA. Breast Cancer Res Treat. 2009 Mar 6.

  30. Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update. Ginsburg O, Ghadirian P, Lubinski J, Cybulski C, Lynch H, Neuhausen S, Kim-Sing C, Robson M, Domchek S, Isaacs C, Klijn J, Armel S, Foulkes WD, Tung N, Moller P, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Breast Cancer Res Treat. 2009; 114 (1): 127-135.

  31. Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology. Lubinski J, Korzen M, Górski B, Cybulski C, Debniak T, Jakubowska A, Jaworska K, Wokolorczyk D, Medrek K, Matyjasik J, Huzarski T, Byrski T, Gronwald J, Masojc B, Lener M, Szymanska A, Szymanska-Pasternak J, Serrano-Fernàndez P, Piegat A, Ucinski R, Domagala P, Domagala W, Chosia M, Kladny J, Gorecka B, Narod S, Scott R. Breast Cancer Res Treat. 2009; 114 (1): 121-126.

  32. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Jakubowska A, Jaworska K, Cybulski C, Janicka A, Szymańska-Pasternak J, Lener M, Narod SA, Lubiński J; the IHCC-Breast Cancer Study Group. Eur J Cancer. 2009; 45 (5): 837-842.

  33. Genetic heterogeneity of 8q24 region in susceptibility to cancer. Wokołorczyk D, Lubiński J, Narod SA, Cybulski C. J Natl Cancer Inst. 2009; 101 (4): 278-279.

  34. Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans DG, Eeles R; EMBRACE, Nogues C, Faivre L, Gesta P; GENEPSO, van Leeuwen FE, Ausems MG, Osorio A; GEO-HEBON, Caldes T, Simard J, Lubinski J, Gerdes AM, Olah E, Fürhauser C, Olsson H, Arver B, Radice P, Easton DF, Goldgar DE. Cancer Epidemiol Biomarkers Prev. 2009; 18 (2): 601-610.

  35. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations. Cybulski C, Gorski B, Huzarski T, Byrski T, Gronwald J, Debniak T, Wokolorczyk D, Jakubowska A, Serrano-Fernández P, Dork T, Narod SA, Lubinski J. J Med Genet. 2009; 46 (2): 132-135.

  36. Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention. Cybulski C, Huzarski T, Byrski T, Gronwald J, Dębniak T, Jakubowska A, Górski B, Wokołorczyk D, Masojć B, Narod SA, Lubiński J. Clin Genet. 2009; 75 (1): 72-78.

  37. Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations. Kaufman B, Laitman Y, Gronwald J, Winqvist R, Irmejs A, Lubinski J, Pylkäs K, Gardovskis J, Miklasevics E, Friedman E. Fam Cancer. 2009; 8 (4): 473-478.

  38. The 4154delA mutation carriers in the BRCA1 gene share a common ancestry. Ozolina S, Sinicka O, Jankevics E, Inashkina I, Lubinski J, Gorski B, Gronwald J, Nasedkina T, Fedorova O, Lyubchenko L, Tihomirova L. Fam Cancer. 2009; 8 (1): 1-4.

  39. Endolymphatic sac tumours and von Hippel-Lindau disease – case report, molecular analysis and histopathological characterization. Krzysztolik K, Cybulski C, Sagan L, Nowacki P, Lubiński J. Folia Neuropathol. 2009; 47 (1): 75-80.

  40. Genetic epidemiology studies in hereditary non-polyposis colorectal cancer. Scott RJ, Lubinski J. Methods Mol Biol. 2009; 472: 89-102.

  41. Genetic structure of Europeans: a view from the North-East. Nelis M, Esko T, Mägi R, Zimprich F, Zimprich A, Toncheva D, Karachanak S, Piskácková T, Balascák I, Peltonen L, Jakkula E, Rehnström K, Lathrop M, Heath S, Galan P, Schreiber S, Meitinger T, Pfeufer A, Wichmann HE, Melegh B, Polgár N, Toniolo D, Gasparini P, D’Adamo P, Klovins J, Nikitina-Zake L, Kucinskas V, Kasnauskiene J, Lubinski J, Debniak T, Limborska S, Khrunin A, Estivill X, Rabionet R, Marsal S, Julià A, Antonarakis SE, Deutsch S, Borel C, Attar H, Gagnebin M, Macek M, Krawczak M, Remm M, Metspalu A. PLoS ONE. 2009; 4 (5): e5472.

2008

  1. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC; CAPP2 Investigators. N Engl J Med. 2008; 359 (24): 2567-2578.

  2. Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Gronwald J, Pijpe A, Byrski T, Huzarski T, Stawicka M, Cybulski C, van Leeuwen F, Lubiński J, Narod SA. Breast Cancer Res Treat. 2008; 112 (3): 581-584.

  3. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Kotsopoulos J, Librach CL, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth PJ, Cummings S, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Cancer Causes Control. 2008; 19 (10): 1111-1119.

  4. A range of cancers is associated with the rs6983267 marker on chromosome 8. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, Matyjasik J, Mierzejewski M, Medrek K, Oszutowska D, Suchy J, Gronwald J, Teodorczyk U, Huzarski T, Byrski T, Jakubowska A, Górski B, van de Wetering T, Walczak S, Narod SA, Lubinski J, Cybulski C. Cancer Res. 2008; 68 (23): 9982-9986.

  5. Lung cancer susceptibility locus at 5p15.33. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, McLaughlin J, Shepherd F, Montpetit A, Narod S, Krokan HE, Skorpen F, Elvestad MB, Vatten L, Njølstad I, Axelsson T, Chen C, Goodman G, Barnett M, Loomis MM, Lubinski J, Matyjasik J, Lener M, Oszutowska D, Field J, Liloglou T, Xinarianos G, Cassidy A; EPIC Study, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, González CA, Ramón Quirós J, Martínez C, Navarro C, Ardanaz E, Larrañaga N, Kham KT, Key T, Bueno-de-Mesquita HB, Peeters PH, Trichopoulou A, Linseisen J, Boeing H, Hallmans G, Overvad K, Tjønneland A, Kumle M, Riboli E, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P. Nat Genet. 2008; 40 (12): 1404-1406.

  6. A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Cybulski C, Wokolorczyk D, Gliniewicz B, Sikorski A, Gorski B, Jakubowska A, Huzarski T, Byrski T, Debniak T, Gronwald J, Lubinski J, Narod SA. Breast Cancer Res Treat. 2008; 112 (2): 367-368.

  7. Familial association of laryngeal, lung, stomach and early-onset breast cancer. Jaworowska E, Serrano-Fernández P, Tarnowska C, Lubinski J, Brzosko M, Flicinski J, Masojc B, Matyjasik J, Scott RJ, Narod SA, Lubinski J. Breast Cancer Res Treat. 2008; 112 (2): 359-361.

  8. Is there any relationship between BRCA1 gene mutation and pancreatic cancer development? Lawniczak M, Gawin A, Białek A, Lubiński J, Starzyńska T. Pol Arch Med Wewn. 2008; 118 (11): 645-649.

  9. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Georgitsi M, De Menis E, Cannavò S, Mäkinen MJ, Tuppurainen K, Pauletto P, Curtò L, Weil RJ, Paschke R, Zielinski G, Wasik A, Lubinski J, Vahteristo P, Karhu A, Aaltonen LA. Clin Endocrinol (Oxf). 2008; 69 (4): 621-627.

  10. Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland. Debniak T, van de Wetering T, Scott R, Nagay L, Cybulski C, Górski B, Jakubowska A, Gronwald J, Masojć B, Huzarski T, Byrski T, Nej-Wołosiak K, Kładny J, Maleszka R, Lubinski J. Eur J Cancer Prev. 2008; 17 (5): 389-391.

  11. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C,Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA; Hereditary Breast Cancer ClinicalStudy Group. J Natl Cancer Inst. 2008; 100 (19): 1361-1367.

  12. An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Osorio A, Pollán M, Pita G, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Preisler-Adams S, Niederacher D, Hofmann W, Gadzicki D, Jakubowska A, Hamann U, Lubinski J, Toloczko-Grabarek A, Cybulski C, Debniak T, Llort G, Yannoukakos D, Díez O, Peissel B, Peterlongo P, Radice P, Heikkinen T, Nevanlinna H, Mai PL, Loud JT, McGuffog L, Antoniou AC, Benitez J. Br J Cancer. 2008; 99 (6): 974-977.

  13. IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer. Reeves SG, Rich D, Meldrum CJ, Colyvas K, Kurzawski G, Suchy J, Lubinski J, Scott RJ. Int J Cancer. 2008; 123 (6): 1339-1343.

  14. Pleomorphic adenoma of salivary glands does not appear to be a BRCA-1-dependent tumour in a Polish cohort. Lubiński J, Tarnowska C, Jaworowska E, Byrski T, Jakubowska A, Górski B, Bień S, Sygut J, Góźdź S, Siołek M, Sulikowski M, Lubiński J. Anticancer Res. 2008; 28 (5B): 3011-3013.

  15. The 3020insC NOD2 gene mutation in patients with ovarian cancer. Magnowski P, Medrek K, Magnowska M, Stawicka M, Kedzia H, Górski B, Lubiński J, Spaczyński M. Ginekol Pol. 2008; 79 (8): 544-549.

  16. The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer. Reeves SG, Mossman D, Meldrum CJ, Kurzawski G, Suchy J, Lubinski J, Scott RJ. Cancer Lett. 2008; 265 (1): 39-44.

  17. MSH6 syndrome. Suchy J, Lubinski J. Hered Cancer Clin Pract. 2008; 6 (2): 103-104.

  18. Lynch syndrome (HNPCC). Kladny J, Lubinski J. Hered Cancer Clin Pract. 2008; 6 (2): 99-102.

  19. Hereditary breast and ovarian cancer. Gronwald J, Byrski T, Huzarski T, Oszurek O, Janicka A, Szymanska-Pasternak J, Górski B, Menkiszak J, Rzepka-Górska I, Lubinski J. Hered Cancer Clin Pract. 2008; 6 (2): 88-98.

  20. DNA testing for variants conferring low or moderate increase in the risk of cancer. Kurzawski G, Suchy J, Cybulski C, Matyjasik J, Debniak T, Górski B, Huzarski T, Janicka A, Szymanska-Pasternak J, Lubinski J. Hered Cancer Clin Pract. 2008; 6 (2): 84-87.

  21. MSH2 and MLH1 testing. Kurzawski G, Suchy J, Lubinski J. Hered Cancer Clin Pract. 2008; 6 (2): 83.

  22. BRCA1 testing. Górski B, Lubinski J. Hered Cancer Clin Pract. 2008; 6 (2): 81-82.

  23. Principles of genetic predisposition to malignancies. Debniak T, Lubinski J. Hered Cancer Clin Pract. 2008; 6 (2): 69-72.

  24. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Int J Cancer. 2008; 122 (9): 2017-2022.

  25. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. Suchy J, Klujszo-Grabowska E, Kladny J, Cybulski C, Wokolorczyk D, Szymanska-Pasternak J, Kurzawski G, Scott RJ, Lubinski J. BMC Cancer. 2008; 8: 112.

  26. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Passini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, Easton DF. Br J Cancer. 2008; 98 (8): 1457-1466.

  27. Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3′ untranslated region polymorphism. Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Benner A, Lubiński J, Scott RJ, Hamann U. BMC Cancer. 2008; 8: 90.

  28. Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers. Cybulski C, Masojc B, Oszutowska D, Jaworowska E, Grodzki T, Waloszczyk P, Serwatowski P, Pankowski J, Huzarski T, Byrski T, Górski B, Jakubowska A, Debniak T, Wokolorczyk D, Gronwald J, Tarnowska C, Lubinski J, Narod SA. Carcinogenesis. 2008; 29 (4): 762-765

  29. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Talseth BA, Ashton KA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Int J Cancer. 2008; 122 (6): 1273-1277

  30. Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers. Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, Wisniowski R, Siolek M, Narod SA, Lubinski J; the Polish Hereditary Breast Cancer Consortium. Breast Cancer Res Treat. 2008; 108 (2): 289-296.

  31. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA. J Clin Oncol. 2008; 26 (7): 1093-1097

  32. BRCA1 mutations and prostate cancer in Poland. Cybulski C, Gorski B, Gronwald J, Huzarski T, Byrski T, Debniak T, Jakubowska A, Wokolorczyk D, Gliniewicz B, Sikorski A, Stawicka M, Godlewski D, Kwias Z, Antczak A, Krajka K, Lauer W, Sosnowski M, Sikorska-Radek P, Bar K, Klijer R, Romuald Z, Malkiewicz B, Borkowski A, Borkowski T, Szwiec M, Posmyk M, Narod SA, Lubinski J. Eur J Cancer Prev. 2008; 17 (1): 62-66.

  33. Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer. Zlowocka E, Cybulski C, Gorski B, Debniak T, Slojewski M, Wokolorczyk D, Serrano-Fernández P, Matyjasik J, van de Wetering T, Sikorski A, Scott RJ, Lubinski J. Int J Cancer. 2008; 122 (3): 583-586.

  34. [HLA-G alleles and risk of early pregnancy loss] Sipak-Szmigiel O, Cybulski C, Ronin-Walknowska E, Lubiński J. Ann Acad Med Stetin. 2008; 54 (1): 60-64.

  35. CHEK2 germline mutations correlate with recurrence rate in patients with superficial bladder cancer. Słojewski M, Złowocka E, Cybulski C, Górski B, Debniak T, Wokołorczyk D, Matyjasik J, Sikorski A, Lubiński J. Ann Acad Med Stetin. 2008; 54 (3): 115-121.

  36. BARD1 and breast cancer in Poland. Jakubowska A, Cybulski C, Szymanska A, Huzarski T, Byrski T, Gronwald J, Debniak T, Gorski B, Kowalska E, Narod SA, Lubinski J. Breast Cancer Res Treat. 2008; 107 (1): 119-122.

  37. Common variants of DNA repair genes and malignant melanoma. Debniak T, Scott RJ, Gorski B, Cybulski C, van de Wetering T, Serrano-Fernandez P, Huzarski T, Byrski T, Nagay L, Debniak B, Kowalska E, Jakubowska A, Gronwald J, Wokolorczyk D, Maleszka R, Kladny J, Lubinski J. Eur J Cancer. 2008; 44 (1): 110-114.

  38. Frequency of mutations related to hereditary haemochromatosis in northwestern Poland. Raszeja-Wyszomirska J, Kurzawski G, Suchy J, Zawada I, Lubinski J, Milkiewicz P. J Appl Genet. 2008; 49 (1): 105-107.

  39. HLA-G polymorphism in a Polish population and reproductive failure. Sipak-Szmigiel O, Cybulski C, Lubinski J, Ronin-Walknowska E. Tissue Antigens. 2008; 71 (1): 67-71.

2007

  1. The VEGF_936_C>T 3’UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiński J, Scott RJ, Hamann U. Cancer Lett. 2007 Dec 31.

  2. RAD51 135G–>C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Gorski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H; German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Spurdle AB, Chen X, Waddell N, Cloonan N; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Am J Hum Genet. 2007; 81 (6): 1186-200.

  3. CYP1B1 and predisposition to breast cancer in Poland. Matyjasik J, Cybulski C, Masojc B, Jakubowska A, Serrano-Fernandez P, Gorski B, Debniak T, Huzarski T, Byrski T, Gronwald J, Zlowocka E, Narod SA, Scott R, Lubinski J. Breast Cancer Res Treat. 2007; 106 (3): 383-388.

  4. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Kotsopoulos J, Lubinski J, Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA; The Hereditary Breast Cancer Clinical Study Group. Breast Cancer Res Treat. 2007; 105 (2): 221-228.

  5. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U. Breast Cancer Res Treat. 2007; 104 (3): 299-308.

  6. Breast cancer susceptibility genes. Lubinski J, Korzen M, Gorski B, Cybulski C, Debniak T, Jakubowska A, Medrek K, Matyjasik J, Huzarski T, Byrski T, Gronwald J, Masojc B, Lener M, Szymanska A, Szymanska-Pasternak J, Fernandez PS, Wokolorczyk D, Piegat A, Ucinski M, Domagala P, Kladny J, Gorecka B, Scott R, Narod S. J BUON. 2007; 12 (1): 23-29

  7. CDKN2A-positive breast cancers in young women from Poland. Debniak T, Cybulski C, Gorski B, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Kowalska E, Oszurek O, Narod SA, Lubinski J. Breast Cancer Res Treat. 2007; 103 (3): 355-359.

  8. The 3′ untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Jakubowska A, Gronwald J, Gorski B, Huzarski T, Byrski T, Benner A, Lubinski J, Scott RJ, Hamann U. Breast Cancer Res Treat. 2007; 104 (1): 67-74.

  9. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, Porteous ME, Jakubowska A, Lubinski J, Gronwald J, Spurdle AB; kConFab, Schmutzler R, Versmold B, Engel C, Meindl A, Sutter C, Horst J, Schaefer D, Offit K, Kirchhoff T, Andrulis IL, Ilyushik E, Glendon G, Devilee P, Vreeswijk MP, Vasen HF, Borg A, Backenhorn K, Struewing JP, Greene MH, Neuhausen SL, Rebbeck TR, Nathanson K, Domchek S, Wagner T, Garber JE, Szabo C, Zikan M, Foretova L, Olson JE, Sellers TA, Lindor N, Nevanlinna H, Tommiska J, Aittomaki K, Hamann U, Rashid MU, Torres D, Simard J, Durocher F, Guenard F, Lynch HT, Isaacs C, Weitzel J, Olopade OI, Narod S, Daly MB, Godwin AK, Tomlinson G, Easton DF, Chenevix-Trench G, Antoniou AC. Consortium of Investigators of Modifiers of BRCA1/2. Cancer Epidemiol Biomarkers Prev. 2007; 16 (7): 1416-1421.

  10. Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U. J Med Genet. 2007; 44 (6): 408-411.

  11. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Pjanova D, Engele L, Randerson-Moor JA, Harland M, Bishop DT, Newton Bishop JA, Taylor C, Debniak T, Lubinski J, Kleina R, Heisele O. Melanoma Res. 2007; 17 (3): 185-191.

  12. ARLTS1 Trp149Stop mutation and the risk of ovarian cancer. Masojc B, Medrek K, Debniak T, Lubinski J, Wyrwicz LS, Koczyk G, Hoffmann M, Rychlewski L. Cancer Res. 2007; 67 (9): 4533.

  13. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Scand J Gastroenterol. 2007; 42 (5): 628-632.

  14. Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling. Gronwald J, Cybulski C, Lubinski J, Narod SA. J Med Genet. 2007; 44 (4): e76.

  15. Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directions. Doherty R, Lubinski J, Manguoglu E, Luleci G, Christie M, Craven P, Bancroft E, Mitra A, Morgan S, Eeles R on behalf of the IMPACT steering committee and collaborators. Her Can Clin Pract 2007; 5 (1): 53-55.

  16. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Cybulski C, Wokolorczyk D, Huzarski T, Byrski T, Gronwald J, Gorski B, Debniak T, Masojc B, Jakubowska A, van de Wetering T, Narod SA, Lubinski J. Breast Cancer Res Treat. 2007; 102 (1): 119-122.

  17. Epistatic relationship between the cancer susceptibility genes CHEK2 and p27. Cybulski C, Gliniewicz B, Sikorski A, Kladny J, Huzarski T, Gronwald J, Byrski T, Debniak T, Gorski B, Jakubowska A, Wokolorczyk D, Narod SA, Lubinski J. Cancer Epidemiol Biomarkers Prev. 2007; 16 (3): 572-576.

  18. Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Makinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T, Robledo M, De Menis E, Weil RJ, Wasik A, Zielinski G, Lucewicz O, Lubinski J, Launonen V, Vahteristo P, Aaltonen LA. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci U S A. 2007; 104 (10): 4101-4105.

  19. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2007; 16 (2): 270-275.

  20. Gronwald J, Byrski T, Huzarski T, Cybulski C, Stawicka M, Szwiec M, Debniak T, Tulman A, Sun P, Oszurek O, Lubinski J, Narod S. A survey of preventive measures among BRCA1 mutation carriers from Poland. Clin Genet. 2007; 71 (2): 153-157.

  21. Cybulski C, Wokolorczyk D, Kladny J, Kurzawski G, Suchy J, Grabowska E, Gronwald J, Huzarski T, Byrski T, Gorski B, Debniak T, Narod SA, Lubinski J. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Eur J Hum Genet. 2007; 15 (2): 237-241. Erratum in: Eur J Hum Genet. 2007; 15 (2): 254. Kurzwaski, Grzegorz

  22. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients. Int J Cancer. 2007; 120 (3): 563-565.

  23. Jaworowska E, Serrano-Fernández P, Tarnowska C, Lubinski J, Kram A, Masojc B, Scott R, Lubinski J. Clinical and epidemiological features of familial laryngeal cancer in Poland. Cancer Detect Prev. 2007; 31 (4): 270-275.

  24. McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet Oncol. 2007; 8 (1): 26-34.

  25. Beiner ME, Finch A, Rosen B, Lubinski J, Moller P, Ghadirian P, Lynch HT, Friedman E, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. Gynecol Oncol. 2007; 104 (1): 7-10.

  26. Cybulski C, Wokolorczyk D, Jakubowska A, Gliniewicz B, Sikorski A, Huzarski T, Debniak T, Narod SA, Lubinski J. DNA Variation in MSR1, RNASEL and E-Cadherin Genes and Prostate Cancer in Poland. Urol Int. 2007; 79 (1): 44-49.

2006

  1. Gronwald J, Huzarski T, Byrski T, Debniak T, Metcalfe K, Narod SA, Lubinski J. Direct-to-patient BRCA1 testing: the Twoj Styl experience. Breast Cancer Res Treat. 2006; 100 (3): 239-245.

  2. Debniak T, Scott R, Masojc B, Serrano-Fernandez P, Huzarski T, Byrski T, Debniak B, Gorski B, Cybulski C, Medrek K, Kurzawski G, van de Wetering T, Maleszka R, Kladny J, Lubinski J. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer. 2006; 119 (11): 2597-2602.

  3. Kurzawski G. Some aspects of molecular diagnostics in Lynch syndrome. Her Can Clin Pract 2006; 4 (4): 197-205.

  4. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients. Cancer Epidemiol Biomarkers Prev. 2006; 15 (11): 2307-2310.

  5. Cybulski C, Wokolorczyk D, Huzarski T, Byrski T, Gronwald J, Gorski B, Debniak T, Masojc B, Jakubowska A, Gliniewicz B, Sikorski A, Stawicka M, Godlewski D, Kwias Z, Antczak A, Krajka K, Lauer W, Sosnowski M, Sikorska-Radek P, Bar K, Klijer R, Zdrojowy R, Malkiewicz B, Borkowski A, Borkowski T, Szwiec M, Narod SA, Lubinski J. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet. 2006; 43 (11): 863-866.

  6. Doherty R, Lubinski J, Manguoglu E, Luleci G, Christie M, Craven P, Bancroft E, Mitra A, Morgan S, Eeles R; IMPACT Steering Committee. AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening. J BUON. 2006; 11 (4): 415-418. Review.

  7. Masojc B, Mierzejewski M, Cybulski C, van de Wetering T, Debniak T, Gorski B, Jaworowska E, Tarnowska C, Lenner M, Scott RJ, Lubinski J. Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene. Breast Cancer Res Treat. 2006; 99 (1): 59-62.

  8. Lubinski J, Gorski B, Huzarski T, Byrski T, Gronwald J, Serrano-Fernandez P, Domagala W, Chosia M, Ucinski M, Grzybowska E, Lange D, Maka B, Mackiewicz A, Karczewska A, Breborowicz J, Lamperska K, Stawicka M, Gozdecka-Grodecka S, Bebenek M, Sorokin D, Wojnar A, Haus O, Sir J, Mierzwa T, Niepsuj S, Gugala K, Gozdz S, Sygut J, Kozak-Klonowska B, Musiatowicz B, Posmyk M, Kordek R, Morawiec M, Zambrano O, Wasko B, Fudali L, Skret J, Surdyka D, Urbanski K, Mitus J, Rys J, Szwiec M, Rozmiarek A, Dziuba I, Wandzel P, Wisniowski R, Szczylik C, Kozak A, Kozlowski W, Narod SA. BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat. 2006; 99 (1): 71-76.

  9. Szymanska-Pasternak J, Szymanska A, Medrek K, Imyanitov EN, Cybulski C, Gorski B, Magnowski P, Dziuba I, Gugala K, Debniak B, Gozdz S, Sokolenko AP, Krylova NY, Lobeiko OS, Narod SA, Lubinski J. CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors. Gynecol Oncol. 2006; 102 (3): 429-431.

  10. Gorski B. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population. Her Can Clin Pract 2006; 4 (3): 142-152.

  11. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat. 2007; 104 (3): 299-308.

  12. Cybulski C, Gorski B, Huzarski T, Byrski T, Gronwald J, Debniak T, Wokolorczyk D, Jakubowska A, Kowalska E, Oszurek O, Narod SA, Lubinski J. CHEK2-positive breast cancers in young Polish women. Clin Cancer Res. 2006; 12 (16): 4832-4835.

  13. Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA. 2006; 296 (2): 185-192.

  14. Debniak T, Scott RJ, Huzarski T, Byrski T, Masojc B, van de Wetering T, Serrano-Fernandez P, Gorski B, Cybulski C, Gronwald J, Debniak B, Maleszka R, Kladny J, Bieniek A, Nagay L, Haus O, Grzybowska E, Wandzel P, Niepsuj S, Narod SA, Lubinski J. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat. 2006; 98 (2): 209-215.

  15. Suchy J, Kurzawski G, Jakubowska K, Rac M, Safranow K, Kladny J, Rzepka-Gorska I, Chosia M, Czeszynska B, Oszurek O, Scott R, Lubinski J. Frequency and nature of hMSH6 germline mutations in Polish patients with colorectal, endometrial and ovarian cancers. Clin Genet. 2006; 70 (1): 68-70.

  16. Ylisaukko-Oja SK, Cybulski C, Lehtonen R, Kiuru M, Matyjasik J, Szymanska A, Szymanska-Pasternak J, Dyrskjot L, Butzow R, Orntoft TF, Launonen V, Lubinski J, Aaltonen LA. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma. Eur J Hum Genet. 2006; 14 (7): 880-883.

  17. Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Gorski B, Cybulski C, Medrek K, Mierzejewski M, Masojc B, Matyjasik J, Zlowocka E, Teodorczyk U, Lener M, Klujszo-Grabowska E, Nej-Wolosiak K, Jaworowska E, Oszutowska D, Szymanska A, Szymanska J, Castaneda J, van de Wetering T, Suchy J, Kurzawski G, Oszurek O, Narod S, Lubinski J. CDKN2A common variant and multi-organ cancer risk-a population-based study. Int J Cancer. 2006; 118 (12): 3180-3182.

  18. Ashton KA, Meldrum CJ, McPhillips ML, Suchy J, Kurzawski G, Lubinski J, Scott RJ. The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria. Her Can Clin Pract 2006; 4 (2): 94-102.

  19. Morgan S, Lubinski J, Manguoglu E, Luleci G, Doherty R, Christie M, Craven P, Bancroft E, Mitra A, Zieba K, Eeles R, IMPACT and AIDIT: Strengthening Research Ties in Eastern Europe; Her Can Clin Pract 2006; 4 (2): 11-112.

  20. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53. Int J Cancer. 2006; 118 (10): 2479-2484.

  21. Jaworowska E, Masojc B, Tarnowska C, Brzosko M, Flicinski J, Serrano-Fernandez P, Matyjasik J, Amernik K, Scott RJ, Lubinski J. Association between early-onset breast and laryngeal cancers. Breast Cancer Res Treat. 2006; 97 (2): 215-219.

  22. Gronwald J, Byrski T, Huzarski T, Narod SA, Lubinski J. Male to female ratio among offspring of BRCA1 mutation carriers. Breast Cancer Res Treat. 2006; 97 (1): 113-114.

  23. Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update. Int J Cancer. 2006; 118 (9): 2281-2284.

  24. Gronwald J, Huzarski T, Byrski B, Medrek K, Menkiszak J, Sun P, Lubinski J, Narod SA Cancer risks in first-degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status. J Med Genet. 2006; 43 (5): 424-428.

  25. Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Rosen B, Kim-Sing C, Isaacs C, Domchek S, Sun P; Hereditary Breast Cancer Clinical Study Group. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol. 2006 May; 7 (5): 402-406. Erratum in: Lancet Oncol. 2006; 7 (6): 453.

  26. Starzynska T, Ferenc K, Wex T, Kahne T, Lubinski J, Lawniczak M, Marlicz K, Malfertheiner P. The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population. Am J Gastroenterol. 2006; 101 (2): 248-254.

  27. Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SA; the Hereditary Breast Cancer Clinical Study Group. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 2006; 8 (2): R15.

  28. Lener MR, Oszutowska D, Castaneda J, Kurzawski G, Suchy J, Nej-Wolosiak K, Byrski T, Huzarski T, Gronwald J, Szymanska A, Szymanska-Pasternak J, Grodzki T, Serwatowski P, Bre Borowicz G, Scott RJ, Lubinski J. Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat. 2006; 95 (2): 141-145.

  29. Gronwald J, Byrski T, Huzarski T, Cybulski C, Sun P, Tulman A, Narod SA, Lubinski J. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat. 2006; 95 (2): 105-109.

  30. Kurzawski G, Suchy J, Lener M, Klujszo-Grabowska E, Kladny J, Safranow K, Jakubowska K, Jakubowska A, Huzarski T, Byrski T, Debniak T, Cybulski C, Gronwald J, Oszurek O, Oszutowska D, Kowalska E, Gozdz S, Niepsuj S, Slomski R, Plawski A, Lacka-Wojciechowska A, Rozmiarek A, Fiszer-Maliszewska L, Bebenek M, Sorokin D, Sasiadek MM, Stembalska A, Grzebieniak Z, Kilar E, Stawicka M, Godlewski D, Richter P, Brozek I, Wysocka B, Limon J, Jawien A, Banaszkiewicz Z, Janiszewska H, Kowalczyk J, Czudowska D, Scott RJ, Lubinski J. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet. 2006; 69 (1): 40-47.

  31. Kotsopoulos J, Lubinski J, Neuhausen SL, Lynch HT, Rosen B, Ainsworth P, Moller P, Ghadirian P, Isaacs C, Karlan B, Sun P, Narod SA. Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Gynecol Oncol. 2006; 100 (1): 83-88.

  32. Nkondjock A, Ghadirian P, Kotsopoulos J, Lubinski J, Lynch H, Kim-Sing C, Horsman D, Rosen B, Isaacs C, Weber B, Foulkes W, Ainsworth P, Tung N, Eisen A, Friedman E, Eng C, Sun P, Narod SA. Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 2006; 118 (1): 103-107.

  33. Serrano-Fernandez P, Gorski B, Debniak T, Byrski T, Huzarski T, Gronwald J, Jakubowska A, Oszurek O, Lubinski J, Consortium Polish Hereditary Cancer: Coverage of the Genetic Background of Breast Cancer in the Polish Population, Her Can Clin Pract 2006; 4 (1): 25-27.

  34. Irmejs A, Miklasevics E, Borosenko V, Gardovskis A, Vanags A, Melbarde-Gorkusa I, Bitina M, Suchy J, Gardovskis J: Pilot Study on Low Penetrance Breast and Colorectal Cancer Predisposition Markers in Latvia, Her Can Clin Pract 2006; 4 (1): 48-51.

  35. Debniak T, Cybulski C, Kurzawski G, Gorski B, Huzarski T, Byrski T, Gronwald J, Suchy J, Masojc B, Mierzejewski M, Lener M, Teodorczyk U, Medrek K, Zlowocka E, Grabowska-Klujszo E, Nej-Wolosiak K, Szymanska A, Szymanska-Pasternak J, Matyjasik J, van de Wetering T, Jakubowska A, Oszurek O, Toloczko-Grabarek A, Castaneda J, Scott R, Narod SA, Lubinski J: Low-risk Genes and Multi-organ Cancer Risk in the Polish Population, Her Can Clin Pract 2006; 4 (1): 52-55.

  36. Gronwald J, Raczynski A, Tarhoni M, Blachowski M, Huzarski T, Byrski T, Toloczko-Grabarek A, Debniak T, Cybulski C, Huzarska J, Oszurek O, Lubinski J: Population Screening for Cancer Family Syndromes in the West Pomeranian Region of Poland, Her Can Clin Pract 2006; 4 (1): 56.

  37. Cybulski C, Huzarski T, Huzarska J, Byrski T, Gronwald J, Oszurek O, Grajczyk J, Sikora L, Lubinski J: Population Screening of CHEK2 Mutations in Poland, Her Can Clin Pract 2006; 4 (1): 57.

  38. Huzarski T, Byrski T, Gronwald J, Kowalska E, Zajaczek S, Gorski B, Huzarska J, Cybulski C, Narod SA, Lubinski J: A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet, Her Can Clin Pract 2006; 4 (1): 58.

2005

  1. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer. 2005; 117 (6): 988-991

  2. Gronwald J, Elsakov P, Gorski B, Lubinski J. High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families. Breast Cancer Res Treat. 2005; 94 (2): 111-113.

  3. Kuokkanen M, Butzow R, Rasinpera H, Medrek K, Nilbert M, Malander S, Lubinski J, Jarvela I. Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden, Int J Cancer. 2005; 117 (1): 90-94.

  4. Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, Isaacs C, Kim-Sing C, Ainsworth P, Sun P, Narod SA. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol. 2005; 23 (30): 7491-6.

  5. Debniak T, Gorski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A, Gozdecka-Grodecka S, Gronwald J, Kowalska E, Haus O, Grzybowska E, Stawicka M, Swiec M, Urbanski K, Niepsuj S, Wasko B, Gozdz S, Wandzel P, Szczylik C, Surdyka D, Rozmiarek A, Zambrano O, Posmyk M, Narod S, Lubinski J. A Common Variant of CDKN2A (p16) Predisposes to Breast Cancer, J Med Genet. 2005; 42 (10): 763-765.

  6. Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs C, Weber B, Kim-Sing C, Foulkes WD, Gershoni-Baruch R, Ainsworth P, Friedman E, Daly M, Garber JE, Karlan B, Olopade OI, Tung N, Saal HM, Eisen A, Osborne M, Olsson H, Gilchrist D, Sun P, Narod SA. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control. 2005; 16 (6): 667-674.

  7. Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbanski K, Mitus J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Toloczko-Grabarek A, Medrek K, Masojc B, Mierzejewski M, Kowalska E, Narod SA, Lubinski J. Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat. 2005; 92 (1): 19-24.

  8. Kurzawski M, Drozdzik M, Suchy J, Kurzawski G, Bialecka M, Gornik W, Lubinski J. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients, Eur J Clin Pharmacol. 2005; 61 (5-6): 389-394.

  9. Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet. 2005; 42 (7): 602-603.

  10. Gronwald J, Byrski T, Huzarski T, Narod SA, Lubinski J. Transmission of mutant alleles to female offspring of BRCA1 carriers in Poland. J Med Genet. 2005; 42 (7): e40.

  11. Lubinski J, Huzarski T, Kurzawski G, Suchy J, Masojc B, Mierzejewski M, Lener M, Domagala W, Chosia M, Teodorczyk U, Medrek K, Debniak T, Zlowocka E, Gronwald J, Byrski T, Grabowska E, Nej K, Szymanska A, Szymanska J, Matyjasik J, Cybulski C, Jakubowska A, Gorski B, Narod SA, The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs, Her Can in Clin Pract 2005; 3 (2): 59-63.

  12. Gardovskis A, Arvids I., Miklasevics E., Borosenko V., Bitina M., Melbarde-Gorkusa I., Vanags A., Kurzawski G, Suchy J, Gorski B, Gardovskis J, Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia, Her Can in Clin Pract 2005; 3 (2): 71-76.

  13. Toloczko-Grabarek A., Sikorski A., Brzosko M., Lubinski J. Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer, Her Can in Clin Pract 2005; 3 (2): 129-134.

  14. Kowalska E, Narod SA, Huzarski T, Zajaczek S, Huzarska J, Gorski B, Lubinski J: Increased Rates of Chromosome Breakage in BRCA1 Carriers are Reduced by Oral Selenium Supplementation, Cancer Epidemiol Biomarkers Prev. 2005; 14 (5): 1302-1306.

  15. Kardas I, Mrozek K, Babinska M, Krajka K, Hadaczek P, Lubinski J, Roszkiewicz A, Kuziemska E, Limon J. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. Oncol Rep. 2005; 13 (5): 949-956.

  16. Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Debniak B, Rozmiarek A, Dziuba I, Zlowocka E, Suchy J, Gorski B, Cybulski C, Mierzejewski M, Masojc B, Medrek K, Oszurek O, Lubinski J. NOD2 variants and the risk of malignant melanoma. Eur J Cancer Prev. 2005; 14 (2): 143-146.

  17. Misiewicz I, Kozar A, Skupinska K, Kowalska E, Lubinski J, Kasprzycka-Guttman T. Inhibition of cell cycle and induction of apoptosis by sulforaphane in cell lines carrying various inherited BRCA1 mutations. Oncol Rep. 2005; 13 (4): 659-665.

  18. Gronwald J, Jauch A, Cybulski C, Schoell B, Bohm-Steuer B, Lener M, Grabowska E, Gorski B, Jakubowska A, Domagala W, Chosia M, Scott RJ, Lubinski J.: Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer. 2005; 114 (2): 230-236.

  19. Huzarski T, Cybulski C, Domagala W, Gronwald J, Byrski T, Szwiec M, Woyke S, Narod SA, Lubinski J. Pathology of breast cancer in women with constitutional CHEK2 mutations. Breast Cancer Res Treat. 2005; 90 (2): 187-189.

  20. Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Zaluga E, Maleszka R, Kladny J, Gorski B, Cybulski C, Gronwald J, Kurzawski G, Lubinski J.: CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res. 2005; 65 (3): 835-839.

  21. Gorski B, Narod SA, Lubinski J. A common missense variant in BRCA2 predisposes to early onset breast cancer. Breast Cancer Res. 2005 Oct 24; 7 (6): R1023-R1027.

  22. Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth P, Foulkes WD, Eisen A, Sun P, Narod SA. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2005; 7 (5): R833-843.

  23. Huzarski T, Lener M, Domagala W, Gronwald J, Byrski T, Kurzawski G, Suchy J, Chosia M, Woyton J, Ucinski M, Narod SA, Lubinski J.: The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat. 2005; 89 (1): 91-93.

2004

  1. Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J. CHEK2 Is a Multiorgan Cancer Susceptibility Gene, Am J Hum Genet. 2004; 75 (6): 1131-1135.

  2. Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod SA.: A protein truncating BRCA1 allele with a low penetrance of breast cancer. J Med Genet. 2004; 41 (12): e130.

  3. Lubinski W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubinski J: Supernormal Electro-Oculograms in Patients with Neurofibromatosis Type 1, Her Can Clin Pract 2004, 2 (4): 193-196.

  4. Debniak T: Familial malignant melanoma – overview, Her Can Clin Pract 2004; 2 (3): 123-130.

  5. Nej K, Bartsch DK, Sina-Frey M, Rieder H, Hahn SA, Lubinski J: The NOD2 3020insC Mutation and The Risk of Familial Pancreatic Cancer? Her Can Clin Pract 2004; 2 (3): 149-150.

  6. Bhuyan PK, Karikò K, Capodici J, Lubinski J, Hook LM, Friedman HM, Weissman D. Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. J Virol. 2004; 78 (19): 10276-10281.

  7. Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber B, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers, J Natl Cancer Inst. 2004; 96 (14): 1094-1098.

  8. Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer. 2004; 110 (5): 683-686.

  9. Debniak T, Gorski B, Scott RJ, Cybulski C, Medrek K, Zlowocka E, Kurzawski G, Debniak B, Kladny J, Bielecka-Grzela S, Maleszka R, Lubinski J. Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Cancer. 2004; 110 (4): 558-562.

  10. Ghadirian P, Lubinski J, Lynch H, Neuhausen SL, Weber B, Isaacs C, Baruch RG, Randall S, Ainsworth P, Freidman E, Horsman D, Tonin P, Foulkes WD, Tung N, Sun P, Narod SA: Smoking and the risk of breast cancer among carriers of BRCA mutation, Int J Cancer 2004; 110 (3): 413-416.

  11. Gawdis-Wojnarska B, Brzosko M, Flicinski J, Marlicz K, Starzynska T, Scott RJ, Lubinski J. Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Gastric Cancer, Her Can Clin Pract 2004; 2 (2): 65-68.

  12. Cybulski C, Matyjasik J, Soroka M, Szymas J, Gorski B, Debniak T, Jakubowska A, Bernaczyk A, Zimnoch L, Bierzynska–Macyszyn G, Trojanowski T, Wierzba-Bobrowicz T, Prudlak E, Markowska–Wojciechowska A, Nowacki P, Roszkiewicz A, Kordek R, Szylberg T, Matyja E, Zielinski K, Wozniewicz B, Taraszewska A, Kozłowski W, Lubinski J. Mutations in the von Hippel-Lindau Tumour Suppressor Gene in Central Nervous System Hemangioblastomas, Her Can Clin Pract 2004; 2 (2): 93-97.

  13. Cybulski C, Huzarski T, Gorski B, Masojc B, Mierzejewski M, Debniak T, Gliniewicz B, Matyjasik J, Zlowocka E, Kurzawski G, Sikorski A, Posmyk M, Szwiec M, Czajka R, Narod SA, Lubinski J: A novel founder CHEK2 mutation is associated with increased prostate cancer risk, Cancer Res 2004; 64 (8): 2677-2679.

  14. Debniak T, Gorski B, Cybulski C, Kurzawski G, Zlowocka E, Kladny J, Chosia M, Lubinski J,: Rarity of germline 1100delC mutation in CHEK2 in patients with malignant melanoma of the skin, Mel Res 2004; 14 (2): 121-124.

  15. Kurzawski G, Suchy J, Kladny J, Grabowska E, Mierzejewski M, Jakubowska A, Debniak, Cybulski C, Kowalska E, Szych Z, Domagala W, Scott RJ, Lubinski J, The NOD2 3020insC mutation and the risk of colorectal cancer, Cancer Research 2004; 64 (5): 1604-1606.

  16. Rzewuska-Lech E, Lubinski J. Breast Cancer and Estrogen, Her Can Clin Pract 2004; 2 (1): 33-38.

  17. Krolewska K, Jakubowska A, Zajaczek S. Breast Cancers with Ocular Metastases are Early Onset, Non-Familial and Non-BRCA1/BRCA2 Tumours, Her Can Clin Pract 2004; 2 (1): 47-48.

  18. Cybulski C, Gorski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojc B, Jakubowska A, Matyjasik J, Zlowocka E, Sikorski A, Narod SA, Lubinski J: NBS1 is a prostate cancer susceptibility gene, Cancer Research 2004; 64 (4): 1215-1219.

  19. Misiewicz I, Skupinska K, Kowalska E, Lubinski J, Kasprzycka-Guttman T: Sulforaphane-mediated induction of a phase 2 detoxifying enzyme NAD(P)H: quinone reductase and apoptosis in human lymphoblastoid cells, Acta Biochim Pol. 2004; 51 (3): 711-721.

  20. Kurzawski G, Suchy J, Debniak T, Kladny J, Lubinski J.: Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool, Ann Oncol. 2004; 15 (4): iv283-4.

  21. Menkiszak J, Gronwald J, Gorski B, Byrski T, Huzarski T, Jakubowska A, Foszczynska-Kloda M, Brzosko M, Flicinski J, Rzepka-Gorska I, Narod SA, Lubinski J. Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2, Eur J Gynaecol Oncol. 2004; 25 (1): 99-100.

  22. Menkiszak J, Rzepka-Gorska I, Gorski B, Byrski T, Huzarski T, Jakubowska A, Foszczynska-Kloda M, Brzosko M, Flicinski J, Rzepka-Gorska I, Narod SA, Lubinski J: Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland, Eur J Gynaecol Oncol 2004; 25 (1): 93-95.

  23. Lubinski J, Phelan CM, Ghadirian P, Lynch HT, Garber J, Weber B, Tung N, Horsman D, Isaacs C, Monteiro AN, Sun P, Narod SA. Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer. 2004; 3 (1): 1-10.

  24. Menkiszak J, Brzosko M, Gorski B, Flicinski J, Jakubowska A, Zebielowicz D, Gronwald J, Huzarski T, Byrski T, Teresinski L, Chosia M, Rzepka-Gorska I, Lubinski J. Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations. J Appl Genet. 2004; 45 (2): 255-263.

  25. Plawski A, Lubinski J, Banasiewicz T, Paszkowski J, Lipinski D, Strembalska A, Kurzawski G, Byrski T, Zajaczek S, Hodorowicz-Zaniewska D, Gach T, Brozek I, Nowakowska D, Czkwaniec E, Krokowicz P, Drews M, Zeyland J, Juzwa W, Slomski R. Novel germline mutations in the adenomatous polyposis coli gene in Polish families with familial adenomatous polyposis. J Med Genet. 2004; 41 (1): e11.

2003

  1. Janiszewska H, Haus O, Lauda-Swieciak A, Pasinska M, Laskowski R, Szymanski W, Gorski B, Lubinski J. Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland. Clin Genet. 2003; 64 (6): 502-508.

  2. Jakubowska A, Scott R, Menkiszak J, Gronwald J, Byrski T, Huzarski T, Gorski B, Cybulski C, Debniak T, Kowalska E, Starzyńska T, Ławniczak M, Narod S, Lubinski J. A High Frequency of BRCA2 Gene Mutations in Polish Families with Ovarian and Stomach Cancer. Eur J Hum Genet, 2003; 11 (12): 955-958

  3. Kladny J, Moeslein G, Myrhoj T, Kurzawski G, Jakubowska A, Debniak T, Petriczko W, Kozlowski M, Amawi A, Flicinski T, Banaszkiewicz A, Richter P, Lubinski J. Nuclear pedigree criteria of suspected HNPCC. Her Can in Clin Pract 2003; 1: 34-38.

  4. Irmejs A, Gardovskis A, Borosenko V, Bitina M, Aigare D, Kurzawski G, Suchy J, Gorski B, Gardovskis J. Hereditary Colorectal Cancer (CRC) Programm in Latvia, Her Ca in Clin Pract 2003; 1: 49-53.

  5. Lynch HT, Lynch JF, Shaw TG, Lubinski J: HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management – a Review, Her Ca in Clin Pract, 2003; 1: 7-18.

  6. Narod S., Lubinski J., Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease, J Natl Cancer Inst. 2003; 95 (20): 1552.

  7. Menkiszak J, Gronwald J, Gorski B, Jakubowska A, Huzarski T, Byrski T, Foszczynska-Kloda M, Haus O, Janiszewska H, Perkowska M, Brozek I, Grzybowska E, Zientek H, Gozdz S, Kozak-Klonowska B, Urbanski K, Miturski R, Kowalczyk J, Pluzanska A, Niepsuj S, Koc J, Szwiec M, Drosik K, Mackiewicz A, Lamperska K, Strozyk E, Godlewski D, Stawicka M, Wasko B, Bebenek M, Rozmiarek A, Rzepka-Gorska I, Narod SA, Lubinski J, Hereditary Ovarian Cancer in Poland, Int J Cancer 2003; 106: 942-945.

  8. Gorski B, Debniak T, Masojc B, Mierzejewski M, Medrek K, Cybulski C, Jakubowska A, Kurzawski G, Chosia M, Scott R, Lubinski J. Germline 657del5 mutation in the NBS1 gene in breast cancer patients, Int J Cancer. 2003 Sep 1; 106 (3): 379-81. Erratum in: Int J Cancer. 2003; 106 (6): 984.

  9. Gronwald J, Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Narod SA, Lubinski J.: Non-random transmission of mutant alleles to female offspring of BRCA1 carriers in Poland, J Med Genet. 2003; 40 (9): 719-720.

  10. Lubinski W, Kurzawski G, Suchy J, Szych Z, Penkala K, Palacz O, Scott RJ, Lubinski J.: Electro-oculographic and electroretinographic studies in HNPCC gene mutation carriers, Ophthalmic Res. 2003; 35 (5): 281-294.

  11. Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Lener M, Mierzejewski M, Masojc B, Medrek K, Kladny J, Zaluga E, Maleszka R, Chosia M, Lubinski J. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin, Melanoma Res. 2003; 13 (4): 365-370.

  12. Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Kladny J, Zaluga E, Fiedorowicz J, Debniak B, Lubinski J. Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation, Eur J Cancer Prev. 2003; 12 (3): 241-245.

  13. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies, Am J Hum Genet. 2003 May; 72 (5): 1117-1130. Epub 2003 Apr. Erratum in: Am J Hum Genet. 2003; 73 (3): 709.

  14. Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojc B, Nej K, Huzarska J, Byrski T, Gorski B, Lubinski J., Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland, Cancer Epidemiol Biomarkers Prev. 2003; 12 (5): 457-459.

  15. Lubinski W, Krzystolik K, Cybulski C, Szych Z, Penkala K, Palacz O, Lubinski J.: Retinal function in the von Hippel-Lindau disease, Doc Ophthalmol. 2003; 106 (3): 271-280.

  16. Lubinski W, Gorski B, Szych Z, Penkala K, Palacz O, Lubinski J. Electroretinographic Changes In Eyes of Patients with BRCA1 Gene Mutation, Ophthalmic Res 2003; 35: 164-169.

  17. Gorski B, Debniak T, Jakubowska A, Cybulski C, Huzarski T, Byrski T, Zlowocka E, Lubinski J.: Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers, J Appl Genet. 2003; 44 (3): 419-423.

2002

  1. Narod SA, Dube MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers, J Natl Cancer Inst, 2002; 94 (23): 1773-1779.

  2. Sutter T, Dansranjavin T, Lubinski J, Debniak T, Giannakudis J, Hoang-Vu C, Dralle H: Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma, Int J Colorectal Dis, 2002; 17 (6): 374-380.

  3. Jakubowska A, Nej K., Huzarski T., Scott RJ, Lubinski J:: BRCA2 gene mutations in families with aggregations of breast and stomach cancers, Br J Cancer, 2002; 87 (8): 888-891.

  4. Kurzawski G, Suchy J, Kladny J, Safranow K, Elsakov P, Kucinskas V, Gardovskis J, Irmejs A, Sibul H, Jakubowska A, Huzarski T, Byrski T, Debniak T, Cybulski C, Gronwald J, Clark J, Gozdz S, Niepsuj S, Slomski R, Plawski A, Lacka-Wojciechowska A, Rozmiarek A, Fiszer-Maliszewska L, Bebenek M, Sorokin D, Stawicka M, Godlewski D, Richter P, Limon J, Brozek I, Wysocka B, Jawien A, Banaszkiewicz Z, Kowalczyk J, Czudowska D, Debiec-Rychter M, Goretzki PE, Moeslein G, Lubinski J. Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and Baltic States, J Med. Genet 2002; 39 (10): e65.

  5. Menkiszak J, Gorski B, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Foszczynska-Kloda M, Flicinski J, Brzosko M, Rzepka-Gorska I, Lubinski J.: Clinical characteristics of hereditary ovarian cancer (HOC) in Poland, Ginekol Pol. 2002; 73 (9): 733-739.

  6. Cybulski C, Krzystolik K, Murgia A, Gorski B, Debniak T, Jakubowska A, Martella M, Kurzawski G, Prost M, Kojder I, Limon J, Nowacki P, Sagan L, Bialas B, Kaluza J, Zdunek M, Omulecka A, Jaskolski D, Kostyk E, Koraszewska-Matuszewska B, Haus O, Janiszewska H, Pecold K, Starzycka M, Slomski R, Cwirko M, Sikorski A, Gliniewicz B, Cyrylowski L, Fiszer-Maliszewska L, Gronwald J, Toloczko-Grabarek A, Zajaczek S, Lubinski J. Germline mutations in von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene; J Med Genet 2002; 39 (7): e38.

  7. Lubinski W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubinski J. Electroretinographic changes in the inner retinal layer of the retained eyes of patients with sporadic unilateral retinoblastoma; Ophthalmic Genet, 2002, Jan; 23 (2): 99-107.

  8. Grabowski M, Huzarski T, Lubinski J, Sikorski A: Survival in patients with rare subtypes of renal cell carcinoma, BJU Int 2002; 89 (6): 599-600.

  9. Kurzawski G, Safranow K, Suchy J, Chlubek D, Lubinski J. Mutation analysis of MLH1 and MSH2 genes performed by using denaturing high performance liquid chromatography; J Biochem and Biophys Methods 2002; 51 (1): 89-100.

  10. Park JG, Vasen HF, Park YT, Park KJ, Peltomaki P, de Leon MP, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lindblom A, Madlensky L, Lynch HT: Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study, Int J Colorectal Dis, 2002; 17 (2): 109-114.

  11. Lubinski J, Gorski B, Kurzawski G, Jakubowska A, Cybulski C, Suchy J, Debniak T, Grabowska E, Lener M, Nej K: Molecular basis of inherited predispositions for tumors, Acta Biochem Pol, 2002; 49 (3): 571-581.

  12. Suchy J, Kurzawski G, Jakubowska A, Lubinski J: Ovarian cancer of endometroid type as part of the MSH6 gene mutation phenotype, J Hum Genet. 2002; 47 (10): 529-531.

  13. Gorski B, Jakubowska A, Huzarski T, Gronwald J, Byrski T, Stawicka M, Huzarska J, Menkiszak J, Kowalska E, Toloczko-Grabarek A, Zajacek S, Rzepka-Gorska I, Gorecka-Szyld B, Wilk G, Foszczynska-Kloda M, Ucinski M, Debniak T, Kladny J, Medrek K, Masojc B, Mierzejewski M, Sieminska M, Raczynski A, Blachowski M, Tarhoni M, Niepsuj S, Gozdz S, Bebenek M, Fiszer-Maliszewska L, Pluzanska A, Haus O, Janiszewska H, Milczarek S, Rawluk J, Limon J, Kupryjanczyk J, Kowalczyk J, Miturski R, Midro A, Zaremba L, Posmyk M, Szczylik C, Godlewski D, Urbanski K, Debniak B, Rozmiarek A, Koc J, Szwiec M, Czudowska D, Kilar E, Grabowska E, Lener M, Falinski R, Rogalska S, Kurzawski G, Suchy J, Cybulski C, Mackiewicz A, Grzybowska E, Lubinski J. Progress in prophylactics, diagnosis and treatment of tumours in BRCA1 mutation carriers; Nowotwory 2002 (Polish).

2001

  1. Oszurek O, Gorski B, Gronwald J, Prosolow Z, Uglanica K, Murinow A, Bobko I, Downar O, Zlobicz M, Norik D, Byrski T, Jakubowska A, Lubinski J. Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families; Clinical Genetics 2001; 60 (6): 470-471.

  2. Jakubowska A, Zajaczek S, Haus O, Limon J, Kostyk E, Krzystolik Z, Lubinski J. Novel RB1 gene constitutional mutations found in Polish patients with familial and/or bilateral retinoblastoma. Hum Mut 2001; 18 (5): 459.

  3. Lubinski W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubinski J. Electrooculogram in patients with neurofibromatosis type 1; Documenta Ophthalmologica 2001; 103: 91-103.

  4. Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Kladny J, Lubinski J. Comparison of Alu-PCR, microsatellite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer; J Cancer Res Clin Oncol 2001; 127: 565-569.

  5. Jakubowska A, Gorski B, Byrski T, Huzarski T, Gronwald J, Menkiszak J, Cybulski C, Debniak T, Hadaczek P, Scott RJ, Lubinski J. Detection of Germline Mutations in the BRCA1 Gene by RNA-Based Sequencing. Hum Mut 2001; 18: 149-156.

  6. De los Rios P, Jack E, Kuperstein G, Lynch H, Lubinski J, Narod SA. Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer. Am J Hum Genet 2001; 68 (2): 546.

  7. Muller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeido M, Edmonston TB, Boland CR, Sutter C, Jass JR, Lindblom A, Lubinski J, MacDermont K, Sanders DSA, Morreau H, Muller A, Oliani C, Orntoft T, Pond De Leon M, Rosty C, Rodrigues-Bigas M, Ruschoff J, Ruszkiewicz A, Sabarrin J, Moeslein G: The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – results of an international collaborative study, Familial Cancer, 2001; 1: 87-92.

  8. Jakubowska A, Gorski B, Kurzawski G, Debniak T, Hadaczek P, Cybulski C, Kladny J, Oszurek O, Scott RJ, Lubinski J. Optimisation of Experimental Conditions for RNA-Based Sequencing of MLH1 and MSH2 Genes. Hum Mut 2001; 17: 52-60.

  9. Kurzawski G, Debniak T, Kladny J, Lubinski J. Age at diagnosis of cancer as predistor of mutation occurrence in families suspected of HNPCC; J. Appl. Genet. 2001; 42 (3): 359-366.

  10. Podolski J, Byrski T, Zajaczek S, Druck T, Zimonjic DB, Popescu NC, Kata G, Borowka A, Gronwald J, Lubinski J., Huebner K.: Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation; J Hum Genet 2001; 46 (12): 685-93.

  11. Druck T, Podolski J, Byrski T, Wyrwicz L, Zajaczek S, Kata G, Borowka A, Lubinski J, Huebner K. The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3) (q33,q21) chromosome translocation; J Hum Genet 2001; 46: 583-589.

  12. Hadaczek P, Gronwald J, Chosia M, Huebner K, Lubinski J. Fhit protein expression in endometrial cancers: no correlation with histological grade; Pol J Pathol 2001, 54 (4): 199-203.

  13. Hadaczek P, Debniak T, Kurzawski G, Jakubowska A, Huzarski T, Huebner K, Lubinski J. Fhit Protein Expression in Hereditary and Sporadic Colorectal Cancers; Pol J Pathol 2001; 53 (3): 125-132.

2000

  1. Debniak T, Kurzawski G, Gorski B, Kladny J, Domagala W, Lubinski J. Value of pedigree/clinical data, immunochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J. Cancer 2000; 36: 49-54.

  2. Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubinski J. Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer. Am. J. Hum. Genet. 2000; 66: 1963-1968.

  3. Lubinski J, Gorski B, Kurzawski G, Jakubowska A, Debniak T, Cybulski C, Byrski T, Huzarski T, Kladny J, Zajaczek S, Gronwald J, Menkiszak J, Krzystolik K, Hadaczek P, Huzarska J. Genetics in early diagnosis of tumours. Wspolczesna Onkologia 2000; 4 (5): 186-189 (Polish).

  4. Lubinski J, Gorski B, Kurzawski G, Jakubowska A, Debniak T, Cybulski C, Byrski T, Huzarski T, Kladny J, Zajaczek S, Gronwald J, Menkiszak J, Krzystolik K, Hadaczek P, Huzarska J. Molecular analyses in diagnosis of high genetic predisposition to tumours. Onkol. Pol. 2000; 3 (2): 93-97 (Polish).

  5. Lubinski J, Gorski B, Kurzawski G, Jakubowska A, Debniak T, Cybulski C, Byrski T, Huzarski T, Kladny J, Zajaczek S, Gronwald J, Menkiszak J, Krzystolik K, Hadaczek P, Huzarska J. Molecular analyses in diagnosis of high genetic predisposition to malignancies, J Clin Biochem Nutr. 2000; 28: 159-165.

  6. Haites N, Moeslein G, Neumann H, Lubinski J, Sobol H, Ponder B, Pharoah P, Vasen H, Weber W. Standards of diagnosis and treatment in families with high genetic predisposition to tumours; Medycyna po Dyplomie 2000; Special Edition, 160 (Polish).

1999

  1. Lubinski J, Wang L, Mastellos D, Sahu A, Lambris JD, Friedman HM. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med. 1999; 190 (11): 1637-1646. Erratum in: J Exp Med 2000; 191 (4): following 746.

  2. Zajaczek S, Jakubowska A, Gorski B, Kurzawski G, Krzystolik Z, Lubinski J. The First Promoter Rb-1 Germ-line de novo Mutation in Patient with Sporadic Unilateral Retinoblastoma; J. Appl. Genet. 1999; 40: 241-247.

  3. Hadaczek P, Kovatich A, Gronwald J, Lubinski J, Huebner K, McCue PA. Loss or Reduction of Fhit expression in renal neoplasias: correlation with histogenic class; Hum Path 1999; 30 (11): 1276-1283.

  4. Gronwald J, Menkiszak J, Huzarski T, Byrski T, Jakubowska A, Zajaczek S, Toloczko A, Podolski J, Gorecka B, Zdziebkowska H, Stanislawski P, Stawicka M, Lubinski J. Clinical genetic services for Familial Breast Cancer in Poland; Disease Markers 1999; 15: 46.

  5. Cybulski C, Krzystolik K, Maher ER, Richard S, Kurzawski G, Gronwald J, Lubinski J. Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene; Hum Genet 1999; 105: 333-336.

  6. Gawrońska-Szklarz B, Lubiński J, Kladny J, Kurzawski G, Bielicki D, Wójcicki M, Sych Z, Musial HD. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps. Exp Toxicol Pathol. 1999; 51 (4-5): 321-325.

  7. Park JG, Vasen HF, Park KJ, Peltomaki P, Ponz de Leon M, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lynch HT. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum 1999; 42: 710-715.

  8. Gronwald J, Hadaczek P, Störkel S, Holtgreve-Grez H, Rabbitts P, Cremer T, Lubinski J. Molecular evidence for derivation of metastatic cells from minor subclones of primary clear renal cell carcinomas. Cancer Detect Prev. 1999; 23 (6): 479-484.

  9. Westerman AM, Entius MM, Boor PP, Koole R, de Baar E, Offerhaus GJ, Lubinski J, Lindhout D, Halley DJ, de Rooij FW, Wilson JH. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum. Mut 1999; 13, 6: 476-481.

  10. Jakubowska A, Gorski B, Kurzawski G, Kladny J, Lubinski J. Gene symbol: MLH1. Disease: Colorectal cancer, non-polyposis; Hum Genet 1999; 105 (3): 293.

  11. Jakubowska A, Gronwald J, Huzarski T, Byrski T, Menkiszak J, Lubinski J. Gene symbol: BRCA2. Disease: Breast cancer; Hum Genet 1999; 105 (3): 293.

  12. Kurzawski G, Kladny J, Debniak T, Lubinski J. Gene Symbol: MLH1. Disease: Colorectal cancer, non-polyposis. Hum Genet 1999, 105 (1-2): 189.

  13. Cybulski C, Krzystolik K, Lubinski J. Gene symbol: VHL. Disease: Von Hippel-Lindau syndrome; Hum Genet 1999; 104 (2): 194.

  14. Kurzawski G. Human Gene Mutations. Gene symbol: MSH2. Disease: Colorectal cancer, non-polyposis; Hum Genet 1999; 104 (1): 116.

  15. Menkiszak J, Gronwald J, Jakubowska A, Huzarski T, Byrski T, Rzepka-Gorska I, Lubinski J. Hereditary ovarian cancer – summarisation of 6-year experience. Nowotwory 1999; 49 (2): 9-12.

  16. Zajaczek S, Lubinski J. Rules of genetic counselling in families with increased risk of cancer. Nowotwory 1999; 49: 83-87 (Polish).

  17. Zajaczek S, Cragg H, Jakubowska A, Gorski B, Krzystolik Z, Cowell JK, Lubinski J. Molecular analysis of a novel large constitutional deletion in patient with retinoblastoma; J. Appl. Genet. 1999; 40: 233-239.

  18. Zajaczek S, Gorski B, Krzystolik Z, Lubinski J. Constitutional Chromosome Instability in Families with Patients Affected by Sporadic Non-Hereditary Retinoblastomas. J. Appl. Genet. 1999; 40: 343-353.

  19. Zajaczek S, Jakubowska A, Gorski B, Kurzawski G, Krzystolik Z, Lubinski J. Frequency and nature of germ-line Rb-1 gene mutations in a series of patients with sporadic unilateral retinoblastoma. Eur. J. Cancer, 1999; 35 (13): 1824-1827.

1998

  1. Zajaczek S, Jakubowska A, Kurzawski G, Krzystolik K, Lubinski J. Age at diagnosis to discriminate those patients for whom constitutional DNA sequencing is appropriate in sporadic unilateral retinoblastoma. Eur. J. Cancer 1998; 34 (12): 1919-1921.

  2. Krzystolik K, Cybulski C, Lubinski J. Von Hippel-Lindau disease. Neurol. Neuchir. Pol. 1998; 32: 1119-1133 (Polish).

  3. Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue P, Pekarsky Y, Ohta M, Huebner K, Lubinski J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Research 1998; 58: 2946-2951.

  4. Menkiszak J, Jakubowska A, Gronwald J, Rzepka-Górska I, Lubiński J. Hereditary ovarian cancer: summary of 5 years of experience. Ginekol Pol. 1998; 69 (5): 283-287. (Polish).

  5. Górski B, Kubalska J, Naruszewicz M, Lubiński J. LDL-R and Apo-B-100 gene mutations in Polish familial hypercholesterolemias. Hum Genet. 1998; 102 (5): 562-565.

  6. Kardas I, Denis A, Babinska M, Gronwald J, Podolski J, Zajaczek S, Kram A, Lubinski J, Limon J. Translocation (X;1) (p11.2;q21) in a Papillary Renal Cell Carcinoma in a 14-Year-Old Girl. Cancer Genet Cytogenet 1998, 101: 159-161.

  7. Gronwald J, Menkiszak J, Toloczko A, Zajaczek S, Kladny J, Kurzawski G, Krzystolik K, Podolski J, Lubinski J. Hereditary Breast Cancer; Pol. J. Pathol. 1998; 49: 59-66.

  8. Gronwald J, Störkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res. 1997; 57 (3): 481-487.

  9. Lubiński J. Hereditary neoplasms–prevention, early diagnosis, treatment. Pol Arch Med Wewn. 1997; 97 Spec No: 34-6. Review. Polish.

  10. Gronwald J, Lubinski J, Zdziarska B. Tamoxifen in chemoprevention of hereditary breast cancer; Wspolcz. Onkol. 1998; 7: 183-184 (Polish).

  11. Kaczmarek-Kanold M, Zajaczek S, Fiszer-Maliszewska L, Lubinski J. Long-term remission of acute myelogenous leukaemia as second tumour after treatment of Wilm’s tumour; Ped. Polska 1998, 7: 233-235 (Polish).

  12. Krzystolik K, Cybulski C, Lubinski J, Zajaczek S, Sochanska M, Toloczko A, Psut G, Gorecka M, Wilk G, Paprzyski W, Sikorski A, Czernicki K, Slojewski M, Gliniewicz B, Krzystolik Z, Lubinski W, Starzycka-Bigaj E, Kostyk E, Prost M, Zdunek M, Omulecka A, Jaskolski J, Koraszewska-Matuszewska B, Chibowski D, Zalewska R, Haus O, Zasada K, Kojder I, Kaczor R, Slosarek J, Wlodarczyk E, Domanski Z, Malukiewicz G, Bidzinski J, Wysocka B, Limon J, Jozwiak J. Early diagnosis of asymptomatic kidney cancers in families with von Hippel-Lindau disease in Poland. Urol. Pol. 1998; 51: 171-181 (Polish).

  13. Kurzawski G, Zajaczek S, Gorski B, Cybulski C, Jakubowska A, Lubinski J. Molecular analyses of DNA and RNA in detection of hereditary predispositions to tumours. Wspolczesna Onkologia 1998; 4: 16–20 (Polish).

  14. Menkiszak J, Rzepka-Gorska I, Gronwald J, Kladny J, Podolski J, Zajaczek S, Toloczko A, Lubinski J. Hereditary Ovarian Cancer – a Guide for Clinicians. Pol. J. Gyn. Investig 1998; 1: 99-106.

  15. Zajaczek S, Fiszer Maliszewska L, Lubinski J. Li-Fraumeni syndrome. Wspolcz. Onkol. 1998; 5: 193-196 (Polish).

1997

  1. Gronwald J, Storkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt Ch, Jauch A, Lubinski J. Comparison of DNA Gains and Losses in Primary Renal Clear Cell Carcinomas and Metastatic Sites; Cancer Research 1997; 57: 481-487.

  2. Kladny J, Bielicki D, Flicinski J, Marlicz K, Lubinski J. Colonoscopies in asymptomatic patients from families suspected of hereditary non-polyposis colorectal cancer. Gastroenterologia Polska 1997; 4: 277-283 (Polish).

  3. Kladny J, Lubinski J. Clinical features of hereditary non-polyposis colorectal cancers in material of Hereditary Cancer Centre in Szczecin. Gastroenterologia Polska 1997; 4: 267-275 (Polish).

  4. Kladny J, Lubinski J. Incidence of hereditary non-polyposis colorectal cancer (HNPCC) in the city of Szczecin, north-west Poland. J. Appl. Genet. 1997; 38: 103-114.

  5. Lubinski J, Zajaczek S, Kladny J, Kurzawski G, Podolski J, Toloczko A, Menkiszak J, Gronwald J, Krzystolik K, Hadaczek P. Hereditary tumours – prophylactics, early diagnosis, treatment. Wspolczesna Onkologia 1997; 1: 5-8 (Polish).

  6. Zajaczek S, Lubinski J. Significance of cytogenetics in genetic counselling for families with hereditary predispositions to tumours. Ginekol. Pol. 1997; S1: 170-184 (Polish).

1996

  1. Hadaczek P, Podolski J, Toloczko A, Kurzawski G, Sikorski A, Huebner K, Rabbitts P, Lubinski J. Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations. Virchows Arch. 1996; 429: 37-42.

  2. Kladny J, Kurzawski G, Lubinski J. Clinical significance of MSH2 gene mutation carrier – status in family suspected of hereditary predisposition to non-polyposis colorectal cancer. Acta Endoscopica Polona 1996; 3: 139-143 (Polish).

  3. Kladny J, Lubinski J. Hereditary non-polyposis colorectal cancer. Pol. Przegl. Chir. 1996; 68: 728-734 (Polish).

  4. Kladny J, Lubinski J. Sub-total colectomy with prophylactic resection of uterus and adnexis in a patient with asymptomatichereditary non-polyposis colorectal cancer. Pol. Przegląd Chir. 1996; 68: 712-714 (Polish).

  5. Kladny J, Zajaczek S, Lubinski J. Increased Constitutional Sensitivity to Bleomycin in Patients with Hereditary Non-Polyposis Colorectal Cancer. J. Appl. Genet. 1996; 37: 385-392.

  6. Lubinski J, Zajaczek S, Kladny J, Kurzawski G, Menkiszak J, Hadaczek P, Cybulski C, Krzystolik K, Toloczko A, Podolski J, Gronwald J. Hereditary tumours – prophylactics, early diagnosis, treatment. Biotechnologia 1996; 4: 201-207.

1993-1995

  1. Zajaczek S, Podolski J, Lubinski J, Roslawska A, Krzystolik Z, Sagan Z. RFLP-PCR in exclusion of Rb gene mutation carrier status; Klin. Onko 1993; 95: 216-218 (Polish).

  2. Kostyk E, Wieckiewicz J, Jasinska A, Zygulska-Mach H, Pietrzyk J, Lubinski J, Zajaczek S, Podolski J. Molecular analyses in families with retinoblastoma. Nowotwory 1994; 44 (1): 57-61 (Polish).

  3. Lubinski J, Hadaczek P, Podolski J, Toloczko A, Sikorski A, McCue P, Druck T, Huebner K. Common regions of deletion in chromosome regions 3p 12 and 3p 14.2 in primary clear cell renal carcinomas. Cancer Research 1994; 54: 3710-3713.

  4. Zajaczek S, Kladny J, Lubinski J. Hereditary predisposition to tumours – rules of diagnosis and management. Nowotwory 1994; 44 (1): 40-49 (Polish).

  5. Druck T, Kastury K, Hadaczek P, Podolski J, Toloczko A, Ohta M, LaForgia S, Lasota J, McCue P, Lubinski J, Huebner K. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res. 1995; 55: 5348-5353.

  6. Kladny J, Lubinski J. HNPCC frequency in registry of Regional Hereditary Cancer Centre in Szczecin. Wybrane zagadnienia z chirurgii 1995; 255-258 (Polish).

  7. Podolski J, Hadaczek P, Gibas L, Grossman BH, Limon J, Huebner K, Lubinski J. Non-isotopic procedure with silver staning of polyacrylamide gels in detection of genomic abnormalities in tumours using microsatellites; Folia Histochemica et Cytobiologica 1995; 33: 117-123.

Najnowsze wpisy